Vitrolife Balance Sheet Health
Financial Health criteria checks 3/6
Vitrolife has a total shareholder equity of SEK12.7B and total debt of SEK2.0B, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are SEK16.3B and SEK3.6B respectively.
Key information
15.6%
Debt to equity ratio
kr1.99b
Debt
| Interest coverage ratio | n/a |
| Cash | kr861.00m |
| Equity | kr12.72b |
| Total liabilities | kr3.61b |
| Total assets | kr16.33b |
Recent financial health updates
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03
Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07Recent updates
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings
Apr 29Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Mar 16Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?
Jan 22Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain
Dec 18
Financial Position Analysis
Short Term Liabilities: VITR's short term assets (SEK1.9B) exceed its short term liabilities (SEK591.0M).
Long Term Liabilities: VITR's short term assets (SEK1.9B) do not cover its long term liabilities (SEK3.0B).
Debt to Equity History and Analysis
Debt Level: VITR's net debt to equity ratio (8.9%) is considered satisfactory.
Reducing Debt: VITR's debt to equity ratio has increased from 0% to 15.6% over the past 5 years.
Debt Coverage: VITR's debt is well covered by operating cash flow (38.1%).
Interest Coverage: Insufficient data to determine if VITR's interest payments on its debt are well covered by EBIT.